The US Court of Appeals for the Federal Circuit affirmed (on its second review) a district court’s ruling upholding the validity of patent claims related to a long-acting injectable dosing regimen, finding that the...more
7/17/2025
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Generic Drugs ,
Inventions ,
Motivation to Combine ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Validity ,
Patents ,
Pharmaceutical Patents